Suzuki E, Okada M
Gan. 1980 Dec;71(6):856-62.
The metabolic fate of N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) was studied in the rat, to investigate the possibility of a relationship between urinary metabolites and organotropic carcinogenicity to the urinary bladder of this N-nitrosamine. The principal urinary metabolite of BBN was identified as N-butyl-N-(3-carboxypropyl)nitrosamine (BCPN). Several minor metabolites characterized were transformation products of BCPN formed by beta-oxidation according to the Knoop mechanism, i.e., N-butyl-N-(2-hydroxy-3-carboxy-propyl)nitrosamine, N-butyl-N-(carboxymethyl)nitrosamine and N-butyl-N-(2-oxopropyl)nitrosamine; glucuronic acid conjugates of BBN and BCPN were also detected. No BBN was detected in the urine. A possible correlation of the urinary excretion of BCPN with selective induction of bladder tumors by BBN in rats is discussed in relation to the carcinogenic action of BCPN.
在大鼠体内研究了N-丁基-N-(4-羟基丁基)亚硝胺(BBN)的代谢命运,以探讨尿液代谢物与该N-亚硝胺对膀胱的器官特异性致癌性之间存在关联的可能性。BBN的主要尿液代谢物被鉴定为N-丁基-N-(3-羧丙基)亚硝胺(BCPN)。所表征的几种次要代谢物是根据克诺普机制通过β-氧化形成的BCPN的转化产物,即N-丁基-N-(2-羟基-3-羧丙基)亚硝胺、N-丁基-N-(羧甲基)亚硝胺和N-丁基-N-(2-氧代丙基)亚硝胺;还检测到了BBN和BCPN的葡萄糖醛酸共轭物。尿液中未检测到BBN。结合BCPN的致癌作用,讨论了BCPN的尿排泄与BBN在大鼠中选择性诱导膀胱肿瘤之间可能存在的相关性。